Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isotretinoin vs. Doxycycline for Acneiform Rash in Patients on MAPK Inhibitors
NCT07629167Phase 2Not yet recruiting
- Sponsor
- University of California, San Francisco
- Start
- Aug 2026
- Primary completion
- Aug 2029
- Countries
- 1
01
Overview
A Phase 2 trial of isotretinoin, doxycycline in acneiform rash, sponsored by University of California, San Francisco. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
isotretinoindoxycycline
03
Conditions
acneiform rash
Beyond the preview
Go deeper on NCT07629167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07629167.